Dopaminergic Genes and Substance Abuse

Advances in Pharmacology

Volumn 42, Issue C, 1997, Pages 1024-1032

  Uhl, George R ^a,b   Vandenbergh, David J ^a   Rodriguez, Lawrence A ^a   Miner, Lucinda ^a   Takahashi, Nobuyuki ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956744403     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60922-9     Document Type: Article

References (41)

1. Uhl G.R., Elmer G.I., Labuda M.C., and Pickens R.W. Genetic influences in drug abuse. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York
2. Goldberg J., Lyons M.J., Eisen S.A., True W.R., and Tsuang M. Genetic influence on drug use: A preliminary analysis of 2674 Vietnam era veteran twins. Behav. Genet. 23 (1993) 552
3. Johnson E.O., van den Bree M.B.M., Uhl G.R., and Pickens R.W. Indicators of genetic and environmental influences in drug abusing individuals. Drug Alcohol Depend. 41 (1996) 17-23
4. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14 (1991) 299-302
5. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5274-5278
6. Roberts D.C.S., and Koob G.F. Description of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17 (1982) 901-904
7. Pettit H.O., Ettenberg A., and Bloom F.E. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84 (1984) 167-173
8. Roberts D.C.S., Corcoran M.E., and Fibiger H.C. On the role of ascending catecholamine systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6 (1977) 615-620
9. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
10. Shimada S., Kitayama S., Lin C.-L., Patel A., Nanthakumar E., Gregor P., and Uhl G.R. Cloning and expression of a cocaine sensitive dopamine transporter cDNA. Science 254 (1991) 576-578
11. + transport. Synapase 15 (1993) 58-62
12. Miner, L. L., Donovan, D. M., Perry, M., Revay, R., Sharpe, L. G., Przedborski, S., Isenwasser, S., Rothman, R. R., Schindler, C., and Uhl, G. R. Cocaine reward: Alteration by regional variant dopamine transporter overexpression. J. Neurosci. (submitted).
13. Harrington C.A., Lewis E.J., Krzemien D., and Chikaraishi D.M. Identification and cell type specifically of the tyrosine hydroxylase gene promoter. Nucleic Acids Res. 15 (1987) 2363-2384
14. Banerjee S.A., Hoppe P., Brilliant M., and Chikaraishi D.M. 5′ Flanking sequences of the rat tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice. J. Neurosci. 12 (1992) 4460-4467
15. Carr G.D., Fibiger H.C., and Phillips A.G. Conditioned place preference as a measure of drug reward. Neuropharmacological Basis of Reward (1984), Oxford, New York 264-319
16. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
17. Drago J., Gerfen C.R., Lachowicz J.E., Steiner H., and Hollon T.R. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. 91 (1994) 12564-12568
18. Miner L.L., Drago J., Chamberlain P.M., Donovan D., and Uhl G.R. Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport 6 (1995) 2314-2316
19. In: Cho A.K., and Segal D.S. (Eds). Amphetamine and its Analogs (1994), Academic Press, San Diego
20. Takahashi, N., Miner, L., Sora, I., Ujike, H., Revay, R., Kostic, V., Przedborski, S., and Uhl, G. R. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity. Proc. Nat. Acad. Sci. USA (in press).
21. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology (1991), Oxford Press, New York
22. Aksoy S., Klener J., and Weinshilboum R.M. Catechol-O-methyltransferase pharmacogenetics: Photoaffinity labelling and Western blot analysis of human liver samples. Pharmacogenetics 3 (1993) 116-122
23. Bertocci B., Miggiano V., Da Prada M., Dembric Z., Lahm H.-W., and Malherbe P. Human catechol-O-methyltransferase: Cloning and expression of the membrane associated form. Proc. Natl. Acad. Sci. 88 (1991) 1416-1420
24. Tenhunen J., Salminen M., Lundstrom K., Kiviluoto T., Savolainen R., and Ulmanen I. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 223 (1994) 1049-1054
25. Vandenbergh, D. A., Zonderman, A., Wang, J., Uhl, G. R., and Costa, P. A. Failure to replicate the association between long-repeat alleles of the novelty seeking and dopamine D4 receptor polymorphisms: Evidence for limited generalization. Mol. Psychia. (in press).
26. Vandenbergh, D. J., Rodriguez, L. A., Miller, I., Uhl, G. R., and Lachman, H. M. A High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Psych. Genetics (in press).
27. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., and Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat. Genet. 12 (1996) 81-84
28. Ebstein E.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E.R., Nemanov L., Katz M., and Belmaker R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet. 12 (1996) 78-80
29. Shock N.W., et al., Normal Human Aging: The Baltimore Longitudinal Study of Aging. NIH Publication No. 84-2450 (1984), U.S. Government Printing Office, Washington, DC
30. Persico A.M., Vandenbergh D.J., Smith S.S., and Uhl G.R. Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol. Psychiatry 34 (1993) 265-267
31. Gelernter J., Kranzler H.R., Satel S.L., and Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmogy 11 (1994) 195-200
32. Cook E.H., Stein M.A., Krasowski M.D., Cox N.J., Olken D.M., Kieffer J.E., and Leventhal B.L. Association of attention deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56 (1995) 993-998
33. Wang, X.-B., Funada, M., Imai, Y., Revay, R., Ujike, H., and Uhl, G. R. rGβ1: A psychostimulant-regulated gene essential for establishing cocaine sensitization J. Neurosci. (submitted)
34. Uhl, G. R., Gold, L. H., Risch, N., and Wilson, A. Analyses of complex behavioral disorders. Proc. Natl. Acad. Sci. USA, 94, (in press).
35. Crabbe J.C., Belknap J.K., and Buck K.J. Genetic animal models of alcohol and drug abuse. Science 264 (1994) 1715-1723
36. Miner L.L., and Marley R.J. Chromosomalmapping of loci influencing sensitivity to cocaine-induced seizures in BXD recombinant inbred strains of mice. Psychopharmacology 117 (1995) 62-66
37. Miner L.L., and Marley R.J. Chromosomal mapping of the psychomotor stimulant effects of cocaine in BXD recombinant mice. Psychopharmacology 122 (1995) 209-214
38. Lachman H., Papolos D.F., Saito T., Yu Y.M., Szurnlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
39. Spielman R.S., and Weinshilboum R.M. Genetics of red cell COMT activity: Analysis of thermal stability and family data. Am. J. Med. Genet. 10 (1981) 279-290
40. Weinshilboum R.M., and Raymond F.A. Inheritance of low erythrocyte catechol-O-methyl transferase activity in man. Am. J. Hum. Genet 29 (1977) 125-135
41. Uhl G., Blum K., Noble E., and Smith S. Substance abuse vulnerability and D2 receptor gene. Trends Neurosci. 16 (1994) 83-88